Acquisition / mergerFiled on NSE ·
Pushpa Jewellers Limited approves Q2 FY2026 financial results and related disclosures
₹20.2 CrAcquisition / merger
Key highlights
- Approved unaudited standalone financial results for half-year ended September 30, 2026, with net profit ₹20.21 crore and EPS ₹8.35
- Statutory auditors S. K. Agrawal and Co issued audit report with unmodified opinion on these results dated November 12, 2026
- Utilized ₹78.88 crore of IPO proceeds (net ₹78.94 crore raised in FY2025-26) across working capital, showroom capital and inventory costs as of September 30, 2026
Original filing
Integrated Filing- Financial
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Rossell Techsys
Aerospace & Defense
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Pushpa Jewellers
Other acquisition / merger filings this fortnight
- Acquisition / mergerIndo NationalIndo National Limited announces unaudited Q2 and H1 FY2026-27 financial results
- Acquisition / mergerKesoram IndustriesKesoram Industries Limited announces unaudited Q2 and H1 financial results for 2026
- Acquisition / mergerPhoenix MillsThe Phoenix Mills Limited updates on selective reduction of ISMDPL equity capital
- Acquisition / mergerZydus LifesciencesZydus Lifesciences completes subscription and joint venture with Zydus Sunshine
- Abans Financial Services announces CEO resignation, new director appointment, and subsidiary incorporation
- Alivus Life Sciences acquires 65.01% stake in IQGEN-X Pharma
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.